Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow CODEXIS, INC.

Get SEC filing alerts via email and in your feed for CODEXIS, INC.

CDXS

CODEXIS, INC.

About CODEXIS, INC.

Codexis is a biotechnology company specializing in enzyme engineering and biocatalysis for pharmaceutical manufacturing and RNAi therapeutics. Its proprietary CodeEvolver platform develops high-performance enzymes to improve drug synthesis efficiency, yield, and sustainability. The company offers enzymatic solutions, contract development, and manufacturing services, targeting large pharma clients and the growing RNAi market with a focus on scalable, environmentally friendly processes.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from CODEXIS, INC.

1
1
CODEXIS, INC. Codexis Reports 102% Revenue Growth to $15.2 Million in Latest Quarter

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
CODEXIS, INC. Codexis Reports $70.4 Million Revenue for Fiscal Year 2025, Driven by 97% Increase in R&D Revenue

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
CODEXIS, INC. Codexis Reports 33% Revenue Decline and $19.6 Million Net Loss in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
CODEXIS, INC. Codexis Reports 92% Revenue Growth to $15.3 Million in Latest Quarter

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
CODEXIS, INC. Codexis Reports 56% Revenue Decline in Q1 2025, Increases Loss from Operations

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
CODEXIS, INC. Codexis Reports $59.3 Million Revenue for Fiscal Year 2024, Down 15% from 2023

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
CODEXIS, INC. Codexis Reports 38% Revenue Growth in Q3, Net Loss Improvement, Amid Restructuring Efforts

Via official filing (AI summary) | over 1 year ago | 0 comments